 | Up a level |
Marti, Stefanie; Hoepner, Andreas G F; Hammer, Helly; Salmen, Anke; Chan, Andrew; Hoepner, Robert (2023). Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis. JAMA network open, 6(11), e2345619. American Medical Association 10.1001/jamanetworkopen.2023.45619
Salmen, Anke; Marti, Stefanie; Hoepner, Andreas G F; Chan, Andrew; Hoepner, Robert (2023). The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data. Frontiers in Pharmacology, 14(1186404), p. 1186404. Frontiers 10.3389/fphar.2023.1186404
Pistor, Maximilian; Hoepner, Robert; Hoepner, Andreas G F; Lin, Yanan; Jung, Simon; Bassetti, Claudio L; Chan, Andrew; Salmen, Anke (2022). Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System. Therapeutic advances in neurological disorders, 15(17562864221129383), p. 17562864221129383. Sage 10.1177/17562864221129383
Pistor, Maximilian; Hoepner, Andreas G F; Lin, Yanan; Jung, Simon; Bassetti, Claudio L; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2021). Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System. Annals of the rheumatic diseases, 80(12), pp. 1633-1635. BMJ Publishing Group 10.1136/annrheumdis-2021-220679
